MIRODENAFIL

Search structure
Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 504G362H0H

Structure
InChI Key MIJFNYMSCFYZNY-UHFFFAOYSA-N
Smile CCCOc1ccc(S(=O)(=O)N2CCN(CCO)CC2)cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1
InChI
InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33)

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H37N5O5S
Molecular Weight 531.68
AlogP 2.45
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 11.0
Polar Surface Area 120.76
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 37.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Phosphodiesterase Phosphodiesterase 5 Phosphodiesterase 5A
- 100 - - -
Enzyme Transferase
- - - - 22.81
Epigenetic regulator Eraser Histone deacetylase HDAC class IIb
- - - - -42.85-3.32

Indications

Mesh Heading Maximum Phase Reference
Kidney Diseases; Renal Insufficiency; Urologic Diseases Phase 1 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 862189-95-5
ChEBI 136049
ChEMBL CHEMBL4297518
DrugBank DB11792
EPA CompTox DTXSID50881265
FDA SRS 504G362H0H
PubChem 135497803
SureChEMBL SCHEMBL3845775
ZINC ZINC000035077050
CONTENTS